You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 776 to 800 of about 5953
Next 25
04/23/2021
10th Annual National Walk to End Brain Tumors and Silent Auction
04/22/2021
IQAI commits to Phase1 study for drug candidate in the treatment of Glioblastoma (GBM), a grade IV brain tumor
Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas
04/20/2021
Novel CAR-T shows ‘promising early signs of clinical efficacy’ for diffuse midline gliomas
04/19/2021
Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma
04/15/2021
Treovir’s Oncolytic Virus Product Extends Survival in Children With Brain Tumors
04/14/2021
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
04/12/2021
Treovir Announces Positive Results of Phase 1 Study of G207 in Pediatric Patients with Recurrent High-Grade Glioma
04/10/2021
Hopes of a cure for brain cancer that killed former Labour MP Tessa Jowell with a new combination treatment in its early trial stages
04/09/2021
ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma
04/08/2021
Dose-Intensified Chemoradiation in Patients With Newly Diagnosed Glioblastoma
04/05/2021
Musella Foundation Copay Assistance Program is now open!
04/01/2021
Chemo for glioblastoma may work better in morning than evening
Racial/Ethnic Disparities in Treatment Pattern and Time to Treatment for Adults With Glioblastoma in the US
03/25/2021
A vaccine targeting mutant IDH1 in newly diagnosed glioma
03/19/2021
Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience
Convection-Enhanced Delivery of a First-in-Class Anti-ß1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging
03/12/2021
Breaking through the blood brain barrier: Northwestern researchers offer hope for a disease with no cure
03/10/2021
OncoSynergy Announces First Patient Treated in First-in-Human Clinical Trial of OS2966 in Recurrent Glioblastoma
03/08/2021
Compassionate use can save lives!
03/06/2021
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
03/02/2021
The UCLA Brain Tumor Center will host part two of its Brain Tumor Virtual Conference on Friday, March 12th
02/28/2021
02/21/2021
The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme
02/20/2021
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma